Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN499207 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Activin A Receptor, Type IB (ACVR1B) antibody
- Antibody type
- Polyclonal
- Antigen
- ACVR1B antibody was raised against a 14 amino acid peptide near the carboxy terminus ofthe human ACVR1B. (ABIN499206)
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Store the antibody undiluted at 2-8°C. Shelf life: one year from despatch.
Submitted references Activin isoforms signal through type I receptor serine/threonine kinase ALK7.
The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development.
Molecular cloning of a novel type I receptor serine/threonine kinase for the TGF beta superfamily from rat brain.
Tsuchida K, Nakatani M, Yamakawa N, Hashimoto O, Hasegawa Y, Sugino H
Molecular and cellular endocrinology 2004 May 31;220(1-2):59-65
Molecular and cellular endocrinology 2004 May 31;220(1-2):59-65
The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development.
Reissmann E, Jörnvall H, Blokzijl A, Andersson O, Chang C, Minchiotti G, Persico MG, Ibáñez CF, Brivanlou AH
Genes & development 2001 Aug 1;15(15):2010-22
Genes & development 2001 Aug 1;15(15):2010-22
Molecular cloning of a novel type I receptor serine/threonine kinase for the TGF beta superfamily from rat brain.
Tsuchida K, Sawchenko PE, Nishikawa S, Vale WW
Molecular and cellular neurosciences 1996 Jun;7(6):467-78
Molecular and cellular neurosciences 1996 Jun;7(6):467-78
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Western blot analysis of ACVR1B in human kidney tissue lysate with AP30015PU-N ACVR1B antibody at 1 ?g/ml in (A) the absence and (B) the presence of blocking peptide.